Dendritic cells presenting tumor antigen

Cancer Immunology Immunotherapy

Volumn 43, Issue 3, 1996, Pages 158-164

  Shurin, Michael R ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

anticancer immunity; biological therapy; dendritic cells; Langerhans cells; tumor immunology

Indexed keywords

ANTIGEN PRESENTING CELL; CONFERENCE PAPER; DENDRITIC CELL; IMMUNOLOGICAL TOLERANCE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; DENDRITIC CELLS; HUMANS; NEOPLASMS; T-LYMPHOCYTES;

EID: 0029954562     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050317     Document Type: Conference Paper

References (71)

1. Agger R, Crowley MT, Witmer-Pack MD (1990) The surface of dendritic cells in the mouse as studied with monoclonal antibodies. Int Rev Immunol 6: 89
2. Alijagic S, Möller P, Artuc M, Jurgovsky K, Czarnetzki BM, Schadendorf D (1995) Dendritic cells generated from peripheral blood transfected with human tyrosinase induce specific T cell activation. Eur J Immunol 25: 3100
3. Austyn JM (1993) The dendritic cell system and anti-tumour immunity. In vivo 7: 193
4. Becker Y (1992) Anticancer role of dendritic cells (DC) in human and experimental cancers - a review. Anticancer Res 12: 511
5. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 55: 1099
6. Boon T, Cerottini JC, Eynde B, Bruggen P, Pel AV (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12: 337
7. Bouloc A, Walker P, Grivel JC, Vogel J, Katz SI (1996) A role for epidermal Langerhans cells in intracutaneous DNA immunization. J Invest Dermatol 106: 830
8. Bujdoso R, Hopkins J, Dutia BM, Young P, McConnell I (1989) Characterization of sheep afferent lymph dendritic cells and their role in antigen carriage. J Exp Med 170: 1285
9. Cassell DJ, Schwartz RH (1994) A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J Exp Med 180: 1829
10. Celluzzi C, Falo LD Jr (1996) Peptide-pulsed epidermal Langerhans cells induce a cytotoxic T lymphocyte response in mice. J Invest Dermatol 106: 881
11. Chaux P, Martin MS, Martin F (1996) T-cell co-stimulation by the CD28 ligand B7 is involved in the immune response leading to rejection of a spontaneously regressive tumor. Int J Cancer 66: 244
12. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS (1992) Costimulation of antitumor immunity by the B7-counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71: 1093
13. Cohen PJ, Cohen PA, Rosenberg SA, Katz SI, Mule JJ (1994) Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur J Immunol 24: 315
14. Crowley M, Inaba K, Steinmann RM (1990) Dendritic cells are the principal cell in mouse spleen bearing immunogenic fragments of foreign proteins. J Exp Med 172: 383
15. Cumberbatch M, Kimber I (1995) Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology 84: 31
16. Falo LD, Condon CA, Thompson KA (1996) Immunization by cutaneous delivery of naked DNA induces CTL mediated, protective tumor immunity. J Invest Dermatol 106: 830
17. Flamand V, Sornasse T, Thielemans K, Demanet C, Bakkus M, Bazin H, Tielemans F, Leo O, Urbain J, Moser M (1994) Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur J Immunol 24: 605
18. Flechner E, Freudenthal P, Kaplan G, Steinman RM (1988) Antigen-specific T lymphocytes efficiently cluster with dendritic cells in the human primary mixed-leukocyte reaction. Cell Immunol 111: 183
19. Freudental PS, Steinman RM (1990) The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc Natl Acad Sci USA 87: 7698
20. Gabrilovich D, Ciernic IF, Nadaf S, Corak J, Carbone DP (1996) Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice can be effective antigen carriers in the therapy of established tumors. Proc Am Assoc Cancer Res Annu Meet 37: 475
21. Grabbe S, Bruvers S, Gallo RL, Knisely TL, Nazareno R, Granstein RD (1991) Tumor antigen presentation by murine epidermal cells. J Immunol 146: 3656
22. Guery J-C, Adorini L (1995) Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells. J Immunol 154: 536
23. Guinan EC, Gribben JG, Boussiotis VA, Freeman GJ, Nadler LM (1994) Pivotal role of the B7:CD28 pathway in transplantation, tolerance and tumor immunity. Blood 84: 3261
24. Hodgson CM, Dearman RJ, Morris AG, Kimber I (1996) Accessory cell requirements for T lymphocyte activation and interferon-γ production in peripheral lymph nodes. Immunol Lett 49: 49
25. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R (1996) Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 2: 52
26. Huang AYC, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961
27. Inaba K, Schuler G, Witmer MD, Valinsky J, Atassi B, Steinman RM (1986) Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes. J Exp Med 164: 605
28. Inaba K, Metlay JP, Crowley MT, Steinman RM (1990) Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific. MHC-restricted T cell in situ. J Exp Med 172: 631
29. Inaba K, Inaba M, Deguchi M, Hagi K, Yasumizu R, Ikehara S, Muramatsu S, Steinman RM (1993) Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA 90: 3038
30. Kast WM, Boog CJP, Roep BO, Voordouw AC, Melief CJM (1988) Failure or success in the restoration of virus-specific cytotoxic T lymphocyte response defects by dendritic cells. J Immunol 140: 3186
31. Katz SI, Tamaki K, Sachs DH (1979) Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282: 324
32. Knight SC, Krecjci J, Malkovsky M, Colizzi V, Gautam A, Asherson GL (1985) The role of the dendritic cells in the initiation of immune responses to contact sensitizers. I. in vivo exposure to antigen. Cell Immunol 94: 427
33. Levine TP, Chain BM (1992) Endocytosis by antigen presenting cells: dendritic cells are as endocytically active as other antigen presenting cells. Proc Natl Acad Sci USA 89: 8342
34. Liu LM, MacPherson GG (1993) Antigen acquisition by dendritic cells: intestinal dendritic cells acquire antigen administered orally and can prime naive T cells in vivo. J Exp Med 177: 1299
35. Lotze MT, Rubin JT, Zeh HJ (1992) New biologic agents come to bat for cancer therapy. Curr Opin Oncol 4: 1116
36. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer PR (1987) Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 166: 1654
37. Macatonia SE, Taylor PM, Knight SC, Askonas BA (1989) Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med 169: 1255
38. Mac William AS, Nelson D, Thomas JA, Holt PG (1994) Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces. J Exp Med 179: 1331
39. Mahnke K, Bhardwai RS, Luger TA, Schwarz T, Grabbe S (1995) Induction of protective tumor immunity against B16F10 melanoma and KLN205 squamous cell carcinoma by dendritic cells. In: Abstracts of the 25th Annual Meeting of European Societies for Dermatological Research, Vienna. p 138
40. Mahnke K, Bhardwai RS, Luger TA, Schwarz T, Grabbe S (1996) Induction of protective tumor immunity against the murine squamous cell carcinoma KLN205 by bone marrow-derived dendritic cells is guided by their migratory capacity. J Invest Dermatol 106: 879
41. Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJ, Ilstad ST, Kast WM, DeLeo AB, Lotze MT (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat Med 1: 1297
42. Mayrhofer G, Holt PG, Papadimitriou JM (1986) Functional characteristics of the veiled cells in afferent lymph from the rat intestine. Immunology 58: 379
43. Mjaaland S, Fossum S (1995) Dendritic leukocytes pulsed with monoclonal antibody-hapten conjugates elicit vigorous primary humoral responses in vivo. Scand J Immunol 41: 305
44. Mohamadzadeh M, Ariizumi K, Sugamura K, Bergstresser PR, Takashima A (1990) Expression of the common cytokine receptor gamma chain by murine dendritic cells including epidermal Langerhans cells. Eur J Immunol 26: 156
45. Moll H, Fuchs H, Blank C, Roellinghoff M (1993) Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T-cells. Eur J Immunol 23: 1595
46. Munn DH, Cheung NK (1990) Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J Exp Med 172: 231
47. Nair S, Babu JS, Dunham RG, Kanda P, Burke RL, Rouse BT (1993) Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cells. J Virol 67: 4062
48. Ossevoort MA, Kleijmeer MJ, Nijman HW, Geuze HJ, Kast WM, Melief CJM (1995) Functional and ultrastructural aspects of antigen processing by dendritic cells. In: Banchereau J, Schmitt D (eds) Dendritic cells in fundamental and clinical immunology. Plenum, New York, p 227
49. Paglia P, Chiodoni C, Rodolfo M, Colombo MP (1996) Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J Exp Med 183: 317
50. Porgador A, Gilboa E (1995) Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 182: 255
51. Porgador A, Snyder D, Gilboa E (1996) Induction of antitumor immunity using bone marrow-generated dendritic cells. J Immunol 156: 2918
52. Reis S, Stahl PD, Austin JM (1993) Phagocytosis of antigens by Langerhans cells in vitro. J Exp Med 178: 509
53. Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone A, Fayhman CG, Inaba K, Steinman RM (1989) Presentation of exogenous protein antigen by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 169: 1169
54. Rosenthal FM, Zier KS, Gansbacher B (1994) Human tumor vaccines and genetic engineering of tumor with cytokine and histoc
55. Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells in maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor OL J Exp Med 179: 1109
56. Sallusto F, Cella M, Danieli C, Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 182: 389
57. Scheicher C, Mehlig M, Dienes H-P, Reske K (1995) Uptake of microparticle-absorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1α and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 25: 1566
58. Shimizu J, Suda T, Yoshioka T, Kosugi A, Fujiwara H, Hamaoka T (1989) Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. J Immunol 142: 1053
59. Siena S, Di Nicola M, Mortarini R, Anichini A, Bregni M, Parmiani G, Gianni AM (1996) Efficient ex-vivo generation of functional dendritic cells (DCs) utilizable for tumor vaccination from blood cell transplants (BCT) in cancer patients. Proc Am Soc Clin Oncol Annu Meet 15: 554
60. Sornasse T, Flamand V, De Becker G, Bazin H, Tielemans F, Thielemans K, Urbain J, Leo O, Moser M (1992) Antigen-pulsed dendritic cells can efficiently induce an antibody response in vivo. J Exp Med 175: 15
61. Steinman RM (1991) The dendritic cells system and its role in immunogenicity. Annu Rev Immunol 9: 271
62. Steinman RM, Cohn ZA (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137: 1142
63. Stigl G, Bergstresser PR (1995) Dendritic cells: a major story unfolds. Immunol Today 16: 330
64. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factors, and TNF-α. J Immunol 154: 5851
65. + cytotoxic T lymphocytes by immunization with syngeneic irradiated HIV-1 envelop derived peptide-pulsed dendritic cells. Int Immunol 5: 849
66. Tazi A, Bouchonnet F, Grandsaigne M, Boumsell L, Hance AJ, Soler P (1993) Evidence that granulocyte-macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers. J Clin Invest 91: 566
67. Thomas R, Lipsky PE (1996) Dendritic cells: origin and differentiation. Stem Cells 14: 196
68. + T cells by B7-1-transfected melanoma cells. Science 259: 368
69. Urban J, Schreiber H (1992) Tumor antigens. Annu Rev Immunol 10: 617
70. Yan Z, Lonati A, Beisert S, Granstein RD (1996) Presentation of tumor-associated antigens by dermal antigen presenting cells. J Invest Dermatol 106: 923
71. Zitvogel L, Mayordomo JI, Tjandrawan T, DeLeo AB, Clarke MR, Lotze MT, Storkus WJ (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell I-associated cytokines. J Exp Med 183: 87